Christopher G Clement insider trades: Midatech Pharma US (DARA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 3, 2013 | DARA | ↑ Buy | 14,000 | $0.71 | $10K | Direct | Jun 4, 2013 (1d) |
| Dec 9, 2009 | SVNT | ↓ Sell | 9,425 | $4.79 | $45K | Direct | Dec 10, 2008 (0d) |
| Apr 14, 2008 | SVNT | ↓ Sell | 7,570 | $19.06 | $144K | Direct | Apr 16, 2008 (2d) |
| Feb 15, 2008 | SVNT | ↓ Sell | 11,112 | $20.00 | $222K | Direct | Feb 20, 2008 (5d) |
| Jan 17, 2008 | SVNT | ↓ Sell | 15,000 | $20.96 | $314K | Direct | Jan 17, 2008 (0d) |
| Jan 14, 2008 | SVNT | ↓ Sell | 15,000 | $22.02 | $330K | Direct | Jan 14, 2008 (0d) |
| Jan 9, 2008 | SVNT | ↓ Sell | 15,170 | $22.69 | $344K | Direct | Jan 9, 2008 (0d) |
| Jan 3, 2008 | SVNT | ↓ Sell | 10,000 | $24.09 | $241K | Direct | Jan 4, 2008 (1d) |
| Dec 10, 2007 | SVNT | ↓ Sell | 11,229 | $15.26 | $171K | Direct | Dec 12, 2007 (2d) |
| Apr 12, 2007 | SVNT | ↓ Sell | 7,608 | $12.00 | $91K | Direct | Apr 16, 2007 (4d) |
| Mar 5, 2007 | SVNT | ↓ Sell | 34,231 | $12.59 | $431K | Direct | Mar 7, 2007 (2d) |
| Feb 15, 2007 | SVNT | ↓ Sell | 7,624 | $14.49 | $110K | Direct | Feb 20, 2007 (5d) |
| Apr 12, 2006 | SVNT | ↓ Sell | 10,313 | $5.87 | $61K | Direct | Apr 13, 2006 (1d) |
| May 18, 2005 | SVNT | ↑ Buy | 15,000 | $3.09 | $46K | Direct | May 19, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christopher G Clement's insider trades
Christopher G Clement is Chief Executive Officer at Midatech Pharma US (DARA). Since May 18, 2005, Christopher has reported 2 open-market purchases worth $56K and 12 sales worth $2.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), option exercises (4 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DARA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.